Does BARICITINIB Cause Interstitial lung disease? 68 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Interstitial lung disease have been filed in association with BARICITINIB (Olumiant). This represents 0.8% of all adverse event reports for BARICITINIB.
68
Reports of Interstitial lung disease with BARICITINIB
0.8%
of all BARICITINIB reports
14
Deaths
36
Hospitalizations
How Dangerous Is Interstitial lung disease From BARICITINIB?
Of the 68 reports, 14 (20.6%) resulted in death, 36 (52.9%) required hospitalization, and 3 (4.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BARICITINIB. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does BARICITINIB Cause?
Drug ineffective (569)
Off label use (479)
Covid-19 (347)
Pulmonary embolism (288)
Rheumatoid arthritis (284)
Headache (216)
Herpes zoster (216)
Pneumonia (216)
Death (206)
Deep vein thrombosis (201)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BARICITINIB Alternatives Have Lower Interstitial lung disease Risk?
BARICITINIB vs BARIUM
BARICITINIB vs BARNIDIPINE
BARICITINIB vs BASILIXIMAB
BARICITINIB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BARICITINIB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED